Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies May 5, 2020Kalyn DabbsPress Releases New license agreement expands Genprex’s oncology franchise Read More
